Clinical AI decision support tools scale as market reaches $15B forecast
The global market for AI-enabled clinical decision support tools is projected to reach $15 billion by 2033. Companies like Abridge, OpenEvidence, and Atropos Health are currently integrating LLM-powered systems into clinical workflows to assist with evidence synthesis and bedside decision-making.
1 source
Daily brief
Get tomorrow's AI brief in your inbox
More stories today
- GOP panics over Big Tech ties as Trump shifts on AI regulation
- Ethan Mollick: Claude's skill creator beats ChatGPT for reusable skills
- Aident Loadout gives agents 27,000+ tools and logs every action
- Etched gains sizable fan base for AI inferencing computers
- Corbell generates technical specs from repository knowledge graphs